GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Revenue

Orion Infusions (DHA:ORIONINFU) Revenue : BDT782.5 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Orion Infusions Revenue?

Orion Infusions's revenue for the three months ended in Dec. 2024 was BDT195.0 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was BDT782.5 Mil. Orion Infusions's Revenue per Share for the three months ended in Dec. 2024 was BDT9.61. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was BDT38.56.

Warning Sign:

Orion Infusions Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Orion Infusions was -4.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Orion Infusions's highest 3-Year average Revenue per Share Growth Rate was 6.10% per year. The lowest was -1.20% per year. And the median was 3.30% per year.


Orion Infusions Revenue Historical Data

The historical data trend for Orion Infusions's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Revenue Chart

Orion Infusions Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 740.87 727.40 829.57 810.15 827.42

Orion Infusions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 202.73 208.93 179.90 198.64 195.05

Competitive Comparison of Orion Infusions's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Infusions's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's Revenue distribution charts can be found below:

* The bar in red indicates where Orion Infusions's Revenue falls into.


;
;

Orion Infusions Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT782.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Infusions  (DHA:ORIONINFU) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Orion Infusions Revenue Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Infusions Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208
Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions Headlines

No Headlines